Bostongene Is A Biotechnology Company Founded In 2015Specializing In Ai Driven Molecular And Immune Profiling For Cancer Treatmentthe Company Integrates Computational Biologymultiomics Analysisand Precision Medicine To Enhance Personalized Oncology Care And Expedite Drug Development Their Ai Powered Multiomics Platform Analyzes Molecular Profilesincluding Tumor Microenvironment And Immune System Datato Provide Actionable Insights For Cliniciansbostongene Also Offers Biomedical Software Solutions That Identify Multiparametric Signatures And Therapeutic Targetsas Well As An Indication Specific Cancer Library To Assist Biopharma Partners In Drug Repurposing And Clinical Trial Optimization Bostongene Collaborates With Healthcare Providersbiopharma Companiesand Academic Institutionsutilizing Its Solutions For Treatment Recommendations And Drug Discoverythe Company Has Received Recognition For Its Innovations In Ai Driven Oncology And Has Secured Significant Funding To Expand Its Platform And Clinical Collaborationsits Mission Is To Improve Cancer Care Through Personalized Therapyultimately Enhancing Patient Survival And Quality Of Life
